Cosmos Health Inc. - COSM Company Short-Term Debt

Graphic logo of Cosmos Health Inc (COSM)

The current debt obligations chart for Cosmos Health Inc. (COSM) demonstrates the financial stability of the holding company, which possesses a vertically integrated structure and moderate pricing power. The value 0.01 shows the current metric value, while the company effectively optimizes costs by outsourcing warehouse logistics to third-party operators. Global distribution reach ensures high business scalability, allowing the company to increase margins without expanding infrastructure.

COSM (Cosmos Health, Inc.) Company Short-Term Debts history from 04/28/2023 to 10/28/2026

Cosmos Health Inc - analytical breakdowns and key metrics (COSM)

- price and consensus price forecast:
Price Chart Cosmos Health|COSM - Fair Value Consensus
- market capitalization data:
Market Value Cosmos Health Inc.|COSM - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Cosmos Health|COSM - Book Capitalization|Market Cap to Net Assets Ratio cosmosholdingsinc.com|COSM - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Cosmos Health Inc.|COSM - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Cosmos Health Inc.|COSM - Company Cumulative Debt|Debt to Book Capitalization Ratio Cosmos Health Inc.|COSM - Company Long-Term Debt|Company Short-Term Debts Cosmos Health
Fundamental company valuation:COSM - Cosmos Health
Signature product of Cosmos Health Inc.

Steady demand for Cosmos Health Inc. (COSM) generics enables the efficient use of leverage to expand distribution. This short-term debt chart reveals obligations due within one year, reflecting the financing intensity of the operating cycle and the dependence of liquidity on interest rates. Growth in this metric during the expansion period accelerates business scaling but requires strict control over the repayment rate.

Competitors of Cosmos Health Inc. (COSM)

Company Short-Term Debt Eli Lilly (LLY)|ABBV: Company Short-Term Loans and Borrowings|AZN (AstraZeneca AB) - Company Short-Term Debt|Novartis Pharma (NVS) - Company Current Liabilities|MRK (Merck & Co., Inc.) - Company Short-Term Debts|Company Short-Term Debts novonordisk.com (NVO)|Amgen (AMGN) - Company Current Liabilities|Company Short-Term Loans and Borrowings Pfizer Inc (PFE)|Company Short-Term Debts Sanofi Aventis|Bristol-Myers Squibb Co. - Company Short-Term Loans and Borrowings|GSK (GSK Corp) - Company Short-Term Debt|TAK: Short-Term Debt|Teva Pharma (TEVA) - Company Short-Term Debt|Dr. Reddy's Laboratories Limited (RDY) - Company Short-Term Debt|Company Short-Term Debts Viatris Corp (VTRS)|Company Short-Term Indebtedness Roivant Corp|ZLAB (Zai Lab Limited) - Company Short-Term Debts|Short-Term Debt Volume BHC (bauschhealth.com)